Hep C: Six weeks of direct-acting antiviral therapy ‘suboptimal’
An Australian-led study comparing six and 12 weeks of therapy was stopped early, researchers report.
Tag: Hepatitis
Hep C blitz in Aussie prisons halves transmission, landmark study finds
The research backs ‘treatment-as-prevention’ for incarcerated drug users and other high-risk groups, the authors say.
Stereotactic body radiotherapy ‘on the rise’ for HCC
Data from 10 Australian centres provides a snapshot of diverse practice in adoption of the emerging therapy.
Does Australia need targeted screening for liver disease?
A trial community-based program in a high-risk population in NSW detected chronic liver disease in 13% of participants.
GP’s care of terminally ill patient ‘reasonable and appropriate’: coroner
An anonymous report to the Victorian coroner raised concerns about the man's treatment.
Alert over shared use of glucose monitors in hotel quarantine
Hundreds of people are being contacted in the wake of revelations that the devices were used on multiple people.
Warning over energy drink link to kidney injury
A patient drank five to six cans a day for several weeks, report US doctors.
Is it safe for hep C patients to be transplant donors?
The DAA revolution has been a success in more ways than one.
Why GPs should say thank you to Sussan Ley
COMMENT: Some people might suggest federal health ministers are a waste of time. Here's one argument in their defence.
